发明名称 Hyaluronate compositions
摘要 The present invention provides compositions suitable for topical administration to a mammalian subject including sodium hyaluronate and a pharmaceutically acceptable excipient. The present invention also provides methods for making and using the same.
申请公布号 US9107882(B2) 申请公布日期 2015.08.18
申请号 US201313915818 申请日期 2013.06.12
申请人 PERNIX THERAPEUTICS HOLDINGS, INC. 发明人 Lewis Robert
分类号 C08B37/00;A61K31/00;A61K31/164;A61K8/73;A61K9/00;A61K31/728;A61K45/06;A61K31/327;A61K31/4174;A61K31/522;A61K31/7056;A61Q19/00 主分类号 C08B37/00
代理机构 Foley & Lardner, LLP 代理人 Foley & Lardner, LLP
主权项 1. A composition suitable for topical administration to a mammalian subject, the composition comprising, by mass, from about 0.05% to about 5% sodium hyaluronate and a pharmaceutically acceptable excipient, wherein from about 0.001 wt % to about 5 wt % of the sodium hyaluronate in the composition has a molecular weight ranging between about 0.01 megadaltons and about 0.4 megadaltons; at least 50 wt % of the sodium hyaluronate in the composition has a molecular weight ranging between about 1.65 and 4.0 megadaltons and less than about 0.001 wt % of the sodium hyaluronate in the composition has a molecular weight above about 4.0 megadaltons; and wherein the pharmaceutically acceptable excipient is predominantly in the liquid phase at ambient temperature.
地址 Morristown NJ US